AI-Based Cancer Detection and the Future of Care

In this episode, host Shikha Jain, MD, speaks with Helio Genomics' Justin Chen Li about the ways in which AI has been incorporated into oncologic care, how this technology can improve care disparities, and more. Welcome to another exciting episode of Oncology Overdrive :13 About Li :18 The interview: 1:10 How did you end up in this field? 1:25 What is AI-based cancer detection? What does Helio Genomics do? ... Is it really science-fiction, or is it actually happening in today's day and age that we can actually use in our clinical practice? 4:07 There's different ways AI has been incorporated into oncologic care. What's different about what you do? 6:25 What is it that you're doing in the HCC (hepatocellular carcinoma) space right now? 7:47 Is this something that can help in that space? Is that why this is so innovative? 9:43 If you could wave a magic wand and say, "We want Helio Genomics to be able to accomplish this," what would you want to make happen for cancer patients from using your technology? 10:45 Do you think there's a way that this could potentially address health care disparities that exist in cancer care and potentially improve the gaps in care that we often see? 12:40 How has COVID and the pandemic impacted your team — your technology, your delivery of care and your planning? … Have there been things that have forced you all to change the way you think about or improve things based on the last couple of years? 15:02 What's next for you? Where do you see yourself growing and going next from here? 18:26 Is this something you envision expanding into other aspects of health care? Is there a way to expand what you're doing outside of cancer care? 19:42 If someone could only listen to 2 to 3 minutes, or the last couple of soundbites of this episode, what would you want them to remember and take away? 21:26 How to contact Li 22:20 Thanks for listening 22:50 Justin Chen Li, is CEO of Helio Genomics, an AI-based cancer detection company focusing on next generation sequencing tests. We'd love to hear from you! Send your comments/questions to Dr. Jain at [email protected]. Follow us on Twitter @HemOncToday and @ShikhaJainMD. Li can be reached on LinkedIn by searching Justin Chen Li, or email [email protected]. Disclosures: Jain reports she is a paid freelance writer for Lippincott. Li is CEO of Helio Genomics.